Laser Therapy in Managing Vaginal Prolapse

National and Kapodistrian University of Athens

Status

Unknown

Conditions

Enterocele

Cystocele

Vaginal Vault Prolapse

Rectocele

Treatments

Device: Erbium Yttrium Aluminum Garnet (Er:YAG) laser

Study type

Interventional

Funder types

Other

Identifiers

NCT03714607

310/26-04-2018

Details and patient eligibility

About

Efficacy of laser therapy in postmenopausal women with symptomatic prolapse stage >1. Assessment tools will include prolapse stage quantification system (POP-Q) and validated condition related questionnaires.

Full description

Postmenopausal women with symptomatic cystocele and/or rectocele stage 2 or 3 will be 1:1 randomly allocated to Er:YAG laser or watchful waiting group. Participants in the Er:YAG laser group will receive laser therapies at monthly intervals, while participants in the watchful waiting group will receive no treatment. All outcomes in both groups will be evaluated at baseline, 4-months and 6-months from baseline.

Enrollment

30 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Symptomatic prolapse stage >1 (cystocele, vaginal vault prolapse, enterocele, rectocele) according to POP-Q System
Negative Pap-smear

Exclusion criteria

Asymptomatic prolapse
prolapse stage <=1
prolapse of uterus
presence of any type of genital infections (i.e herpes, vaginitis etc)
vaginal bleeding
underlying pathologies that could interfere in patients compliance (i.e psychiatric)